"A Santa Casa é referência em diversas especialidades médicas em Curitiba e também em todo o Paraná. Urgências e emergências humanizadas, 24 horas por dia. As especialidades médicas, além dos serviços de enfermagem, fisioterapia, odontologia, nutrição, psicologia, educação física e farmácia, que complementam todos os tratamentos, têm como princípio perceber e atender cada paciente como pessoa, com suas múltiplas necessidades. Isso é atuar com respeito à história e à comunidade."

During the past decade, Irmandade da Santa Casa de Misericordia de Curitiba conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Irmandade da Santa Casa de Misericordia de Curitiba" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Ache Laboratorios Farmaceuticos S.A." with 1 trials sponsored, "Alaunos Therapeutics" with 1 trials sponsored, "Morphotek" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irmandade da Santa Casa de Misericordia de Curitiba" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Fresenius AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Irmandade da Santa Casa de Misericordia de Curitiba" are "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Disease" (1 trials) and "Deep Vein Thrombosis" (1 trials). Many other conditions were trialed in "Irmandade da Santa Casa de Misericordia de Curitiba" in a lesser frequency.

Most popular intervention types in "Irmandade da Santa Casa de Misericordia de Curitiba" are "Drug" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "Carboplatin" (1 trials), "Circaid" (1 trials) and "Farletuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irmandade da Santa Casa de Misericordia de Curitiba" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Irmandade da Santa Casa de Misericordia de Curitiba". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Irmandade da Santa Casa de Misericordia de Curitiba, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Irmandade da Santa Casa de Misericordia de Curitiba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".